“To sleep perchance to dream.” This Shakespearean line may seem an unusual opening to an article on the treatment of type 2 diabetes but a discussion about such treatment in 2007 has to pay some attention to the DREAM (diabetes reduction assessment with ramapril and rosiglitazone medication trial) published in The Lancet and New England [...]
Uncertainty still surrounds the treatment of diabetic patients, part one
AIDS and sexual violence stalk a landscape of beauty and colour
Kenya is a vast land, a natural environment of great beauty full of colour and tradition. One of Africa’s foremost tourist destinations, its people are warm and gracious. But away from the famous coastline of Mombasa and the game parks, most Kenyans live in poverty and its people face numerous challenges. According to the World [...]
Symptoms of depression linked to early stages of coronary artery disease
Depressive symptoms may be associated with thickening arteries, which may reflect an early sign of coronary artery disease. Researchers looked at 324 men and women who were an average of 60.6 years old. At the beginning of the study, participants attended 11 visits in a five-month period, including a medical screening; testing for cardiovascular risk [...]
Patients who get ICDs for prevention need fewer driving restrictions
Patients who receive implantable cardioverter defibrillators (ICD) as a preventative measure don’t need the same driving restrictions as people who get an ICD after surviving a life-threatening heart rhythm disturbance, according to an updated scientific statement from the American Heart Association and the Heart Rhythm Society. In preparing the new advisory, the writing committee reviewed [...]
Intensive atorvastatin treatment cuts hospital time for heart failure
Intensive treatment with atorvastatin in patients with stable coronary disease significantly reduces hospitalisations for heart failure, a new study has found. In the study, doctors randomised 10,001 patients with stable coronary disease to treatment with 80 mg per day or 10 mg per day of atorvastatin and followed them up for a median of 4.9 [...]
Aprotinin limits loss of blood but it could increase risk of death after bypass surgery
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study. In all, more than four million patients worldwide have received aprotinin since 1985, principally during cardiac surgery. The safety of aprotinin came under [...]
Blindness terrifies teens, but few realise link with smoking
Doctors’ own fear of death can be linked to hastening death of sick newborns
Doctors who fear their own death say they are more prepared than other doctors to hasten the death of sick newborns for whom further medical treatment is considered futile, new research has found. Neonatologists in New Zealand and Australia were asked questions about their ethical practice and to complete the Multidimensional Fear of Death Scale [...]
An aggressive research agenda is needed to fight metabolic syndrome
For most of the 20th century, cardiovascular disease was identified as the major cause of morbidity and mortality in the developed world. During this period considerable efforts were made to understand the underlying biology of the disease and to identify the contributing risk factors. Towards the end of the century a clustering of cardiovascular risk [...]
Statin therapy linked to regression of coronary atherosclerosis
An analysis of data from four clinical trials suggests that statin therapy is associated with regression of coronary atherosclerosis when low-density lipoprotein cholesterol (LDL-C) is substantially reduced and high-density lipoprotein cholesterol (HDL-C) is increased. Despite such findings, it remains to be determined whether this degree of atherosclerosis regression will translate to meaningful reductions in cardiovascular [...]